PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

HIV Testing Among Transgender Women and Men - 27 States and Guam, 2014-2015.

Abstract Transgender persons are at high risk for human immunodeficiency virus (HIV) infection; in a recent analysis of the results of over nine million CDC funded HIV tests, transgender women* had the highest percentage of confirmed positive results (2.7%) of any gender category (1). Transgender men,(†) particularly those who have sex with cisgender(§) men, are also at high risk for infection (2). HIV testing is critical for detecting and treating persons who are infected and delivering preventive services to those who are uninfected. CDC recommends that persons at high risk for HIV infection be screened for HIV at least annually, although transgender persons are not specified in the current recommendations. CDC analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS) to describe HIV testing among transgender women and men and two cisgender comparison groups in 27 states and Guam. After adjusting for demographic characteristics, transgender women and men had a lower prevalence of ever testing and past year testing for HIV (35.6% and 31.6% ever, and 10.0% and 10.2% past year, respectively) compared with cisgender gay and bisexual men (61.8% ever and 21.6% past year) and instead reported testing at levels comparable to cisgender heterosexual men and women (35.2% ever, and 8.6% past year). This finding suggests that transgender women and men might not be sufficiently reached by current HIV testing measures. Tailoring HIV testing activities to overcome the unique barriers faced by transgender women and men might increase rates of testing among these populations.
PMID
Related Publications

Social Media Use and HIV-Related Risk Behaviors in Young Black and Latino Gay and Bi Men and Transgender Individuals in New York City: Implications for Online Interventions.

State-specific prevalence of selected chronic disease-related characteristics--Behavioral Risk Factor Surveillance System, 2001.

Barriers and facilitators to HIV testing among young men who have sex with men and transgender women in Kingston, Jamaica: a qualitative study.

HIV Risk, prevention, and testing behaviors among heterosexuals at increased risk for HIV infection--National HIV Behavioral Surveillance System, 21 U.S. cities, 2010.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Authors

Mayor MeshTerms
Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28837547
OWN - NLM
STAT- MEDLINE
DA  - 20170824
DCOM- 20170828
LR  - 20170828
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 33
DP  - 2017 Aug 25
TI  - HIV Testing Among Transgender Women and Men - 27 States and Guam, 2014-2015.
PG  - 883-887
LID - 10.15585/mmwr.mm6633a3 [doi]
AB  - Transgender persons are at high risk for human immunodeficiency virus (HIV)
      infection; in a recent analysis of the results of over nine million CDC funded
      HIV tests, transgender women* had the highest percentage of confirmed positive
      results (2.7%) of any gender category (1). Transgender men,dagger particularly
      those who have sex with cisgender section sign men, are also at high risk for
      infection (2). HIV testing is critical for detecting and treating persons who are
      infected and delivering preventive services to those who are uninfected. CDC
      recommends that persons at high risk for HIV infection be screened for HIV at
      least annually, although transgender persons are not specified in the current
      recommendations. CDC analyzed data from the Behavioral Risk Factor Surveillance
      System (BRFSS) to describe HIV testing among transgender women and men and two
      cisgender comparison groups in 27 states and Guam. After adjusting for
      demographic characteristics, transgender women and men had a lower prevalence of 
      ever testing and past year testing for HIV (35.6% and 31.6% ever, and 10.0% and
      10.2% past year, respectively) compared with cisgender gay and bisexual men
      (61.8% ever and 21.6% past year) and instead reported testing at levels
      comparable to cisgender heterosexual men and women (35.2% ever, and 8.6% past
      year). This finding suggests that transgender women and men might not be
      sufficiently reached by current HIV testing measures. Tailoring HIV testing
      activities to overcome the unique barriers faced by transgender women and men
      might increase rates of testing among these populations.
FAU - Pitasi, Marc A
AU  - Pitasi MA
FAU - Oraka, Emeka
AU  - Oraka E
FAU - Clark, Hollie
AU  - Clark H
FAU - Town, Machell
AU  - Town M
FAU - DiNenno, Elizabeth A
AU  - DiNenno EA
LA  - eng
PT  - Journal Article
DEP - 20170825
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Behavioral Risk Factor Surveillance System
MH  - Female
MH  - Guam
MH  - HIV Infections/*prevention & control
MH  - Health Services Accessibility
MH  - Humans
MH  - Male
MH  - Mass Screening/*statistics & numerical data
MH  - Middle Aged
MH  - Risk Assessment
MH  - Transgender Persons/*psychology/statistics & numerical data
MH  - United States
MH  - Young Adult
EDAT- 2017/08/25 06:00
MHDA- 2017/08/29 06:00
CRDT- 2017/08/25 06:00
AID - 10.15585/mmwr.mm6633a3 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):883-887. doi:
      10.15585/mmwr.mm6633a3.